280.68
Veeva Systems Inc stock is traded at $280.68, with a volume of 1.73M.
It is up +2.12% in the last 24 hours and up +13.74% over the past month.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
See More
Previous Close:
$274.84
Open:
$276.84
24h Volume:
1.73M
Relative Volume:
0.92
Market Cap:
$45.44B
Revenue:
$3.32B
Net Income/Loss:
$941.65M
P/E Ratio:
49.98
EPS:
5.6161
Net Cash Flow:
$1.64B
1W Performance:
+7.87%
1M Performance:
+13.74%
6M Performance:
+57.59%
1Y Performance:
+0.27%
Veeva Systems Inc Stock (VEEV) Company Profile
Name
Veeva Systems Inc
Sector
Industry
Phone
925-452-6500
Address
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV vs TEM, BTSG, TXG, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VEEV
Veeva Systems Inc
|
280.68 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
85.01 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
56.59 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TXG
10 X Genomics Inc
|
85.71 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
|
HNGE
Hinge Health Inc
|
95.57 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Downgrade | Citigroup | Buy → Neutral |
| Feb-17-26 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-26 | Resumed | Goldman | Sell |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-12-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-07-25 | Upgrade | TD Cowen | Hold → Buy |
| Sep-08-25 | Upgrade | JP Morgan | Neutral → Overweight |
| May-29-25 | Reiterated | Needham | Buy |
| Jan-23-25 | Downgrade | Goldman | Buy → Sell |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-19-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Initiated | Exane BNP Paribas | Outperform |
| Aug-27-24 | Reiterated | Citigroup | Buy |
| Jul-09-24 | Initiated | BTIG Research | Buy |
| Oct-25-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-13-23 | Initiated | Jefferies | Buy |
| Jun-28-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-01-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-17-23 | Downgrade | Truist | Buy → Hold |
| Feb-23-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-04-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-06-22 | Initiated | Cowen | Market Perform |
| Dec-02-22 | Reiterated | Needham | Buy |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-27-22 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | Goldman | Buy |
| Jun-21-22 | Resumed | Guggenheim | Buy |
| Mar-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-28-22 | Initiated | Truist | Buy |
| Jan-07-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-06-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Resumed | Stifel | Buy |
| Sep-02-21 | Reiterated | BofA Securities | Buy |
| Sep-02-21 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-02-21 | Reiterated | Needham | Buy |
| Sep-02-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Initiated | Cowen | Outperform |
| Mar-31-21 | Upgrade | UBS | Sell → Neutral |
| Jan-07-21 | Resumed | KeyBanc Capital Markets | Overweight |
| Dec-09-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-14-20 | Resumed | UBS | Sell |
| Aug-28-20 | Reiterated | Needham | Buy |
| Jul-23-20 | Initiated | FBN Securities | Outperform |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Jun-08-20 | Initiated | Citigroup | Buy |
| May-29-20 | Reiterated | Needham | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-19-20 | Initiated | Robert W. Baird | Outperform |
| Feb-14-20 | Initiated | Piper Sandler | Overweight |
| Jan-13-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-27-19 | Reiterated | Canaccord Genuity | Hold |
| Sep-26-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-28-19 | Reiterated | Needham | Buy |
| Jun-07-19 | Initiated | Goldman | Neutral |
| May-30-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| May-24-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-27-19 | Reiterated | Needham | Buy |
View All
Veeva Systems Inc Stock (VEEV) Latest News
Veeva Systems: Excellent Execution, But Upside Potential Has Waned (Rating Downgrade) - Seeking Alpha
Form 4 Veeva Systems Inc Class A For: 27 September By Investing.com - Investing.com India
Veeva Systems (NYSE:VEEV) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Veeva Systems (VEEV) Outperforms Broader Market: What You Need to Know - Yahoo Finance
What Is Behind Veeva (NYSE:VEEV) AI Study Builder Move? - Kalkine Media
Veeva Systems Inc (VEEV): GF Score of 100 Signals Strong Outperf - gurufocus.com
Form 4 Veeva Systems Inc Class A For: 25 September - Investing.com India
Form 4 Veeva Systems Inc Class A For: 25 September By Investing.com - Investing.com Canada
Veeva Systems Inc. (VEEV) stock price, news, quote and history - Yahoo Finance Australia
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup - Zacks Investment Research
If You Invested $100 In Veeva Systems Stock 10 Years Ago, You Would Have This Much Today - Benzinga
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients - Yahoo Finance
VEEV News | VEEVA SYSTEMS INC-CLASS A (NYSE:VEEV) - ChartMill
EXCLUSIVE: AI Has A Blind Spot, Here Are 3 Overlooked Stocks - Benzinga
Veeva Systems (VEEV) Could Be 29% Undervalued Following Its New AI Study Design Launch - Yahoo Finance
Veeva SystemsVault CRM Extends Market Leadership as another Top 20 Biopharma Chooses Veeva - marketscreener.com
Veeva Launches Study Builder Agent to Accelerate Clinical Research - Intellectia AI
New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day - Veeva
Veeva Systems (VEEV) Launches AI Study Builder Agent - TradingView
Can Veeva Systems (NYSE:VEEV) Hold Today’s Attention? - Kalkine Media
How Veeva Systems Inc. Class A (VEEV) Affects Rotational Strategy Timing - Stock Traders Daily
Veeva Systems Inc. (VEEV) Stock Forecasts - Yahoo Finance
Is It Too Late to Buy Veeva Systems Inc (VEEV) After 3.8% Rally? GF Value Says Undervalued - gurufocus.com
VEEV Stock Climbs As AI Vault CRM Momentum Fuels Target Hikes - StocksToTrade
Veeva Systems (NYSE:VEEV) Trading Up 2.8%What's Next? - MarketBeat
Effective Planning and Engagement for Patient Support Services - Veeva
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing - Your Wyoming Link
Veeva Systems gains on new top 20 biopharma win (VEEV:NYSE) - Seeking Alpha
Why Veeva Systems (VEEV) Stock Is Up Today - Quiver Quantitative
Vault CRM Extends Market Leadership as Another Top 20 Biopharma Chooses Veeva - Veeva
Veeva Systems adds top 20 biopharma client for Vault CRM By Investing.com - Investing.com Canada
Oxford Biomedica Advances Global Quality Transformation with Veeva Quality Cloud - TradingView
Veeva Systems Inc. $VEEV Shares Sold by Andra AP fonden - MarketBeat
ETFs Are Net Sellers of Veeva Systems (VEEV) on Sept. 23 - gurufocus.com
What Is Veeva Systems (VEEV) Telling Investors With Its New Falcon Router? - simplywall.st
Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today - Yahoo Finance
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar? - Zacks Investment Research
Veeva Systems stock gains as AI tools expand its growth case - ad-hoc-news.de
Veeva Systems (NYSE: VEEV) EVP details stock and option stake - Stock Titan
Veeva Expands Amgen Partnership With Global Vault CRM Rollout Plan - Yahoo Finance
Veeva Launches Falcon Router to Enhance Safety Event Handling - intellectia.ai
Veeva Systems launches AI routing tool for drug safety reports By Investing.com - Investing.com Canada
A new tool is planned to send drug-safety reports to the right teams without manual sorting. - Stock Titan
Veeva Introduces Falcon Router for Agentic Triage of All Reporting Channels - PR Newswire
Veeva Systems Inc. (VEEV) Stock Analysis: Assessing Growth Potential with a 14.25% Upside - DirectorsTalk Interviews
Nykredit A S Takes Position in Veeva Systems Inc. $VEEV - MarketBeat
Integrated Wealth Concepts LLC Sells 4,720 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems stock holds firm as investors digest recent insider sales - AD HOC NEWS
CFRA upgrades Veeva Systems (VEEV) to a Buy - The Globe and Mail
Veeva Systems Inc. (VEEV) Stock forecasts - uk.finance.yahoo.com
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know - Yahoo Finance
Veeva Systems Inc Stock (VEEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):